PROSTACYCLIN: HAEMODYNAMIC AND METABOLIC EFFECTS IN PATIENTS WITH CORONARY ARTERY DISEASE
- 1 March 1981
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 317 (8220), 569-572
- https://doi.org/10.1016/s0140-6736(81)92028-6
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Haemodynamic changes induced by prostacyclin in man.Heart, 1980
- Myocardial lactate extraction: multi-determined metabolic function.Circulation, 1980
- SUCCESSFUL THERAPY OF ADVANCED ARTERIOSCLEROSIS OBLITERANS WITH PROSTACYCLINThe Lancet, 1979
- Prevention of blockage of partially obstructed coronary arteries with prostacyclin correlates with inhibition of platelet aggregationProstaglandins, 1979
- Prostacyclin is a circulating hormoneNature, 1978
- COMPARISON OF THE VASODEPRESSOR EFFECTS OF PROSTACYCLIN AND 6‐OXO‐PROSTAGLANDIN F1α WITH THOSE OF PROSTAGLANDIN E2 IN RATS AND RABBITSBritish Journal of Pharmacology, 1978
- The generation of prostacyclin by arteries and by the coronary vascular bed is reduced in experimental atherosclerosis in rabbitsProstaglandins, 1977
- Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endotheliumThrombosis Research, 1977
- Effects of prostacyclin (PGX) on cyclic AMP concentrations in human plateletsProstaglandins, 1977
- A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregationProstaglandins, 1976